2020 Virtual AHA Scientific Sessions

On November 13, 2020, Resverlogix presented an oral presentation entititled: "BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes from Patients with Cardiovascular Disease and Type 2 Diabetes", as well as two poster presentations at the 2020 American Heart Association (AHA) Scientific Sessions virtual experience.

Copies of  all three presentations can be accessed HERE.